Search Results - "J T, van Golde Ron"

Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience by Vriens, Ingeborg J. H., ter Welle-Butalid, Elena M., de Boer, Maaike, de Die-Smulders, Christine E. M., Derhaag, Josien G., Geurts, Sandra M. E., van Hellemond, Irene E. G., Luiten, Ernest J. T., Dercksen, M. Wouter, Lemaire, Bea M. D., van Haaren, Els R. M., Vriens, Birgit E. P. J., van de Wouw, Agnes J., van Riel, Anne-marie M. G. H., Janssen-Engelen, Sandra L. E., van de Poel, Marlène H. W., Schepers-van der Sterren, Ester E. M., van Golde, Ron J. T., Tjan-Heijnen, Vivianne C. G.

“…Purpose We assessed the uptake of fertility preservation (FP), recovery of ovarian function (OFR) after chemotherapy, live birth after breast cancer, and…”
Get full text

Preconceptional evaluation of women with recurrent pregnancy loss: the additional value of assessing vascular and metabolic status by Habets, Denise H J, Schiffer, Veronique M M M, Kraneburg, Lisa P A, de Krom, Femke J W, Gürtekin, Irem, van Bree, Bo E, van Golde, Ron J T, Wieten, Lotte, Spaanderman, Marc E A, Al-Nasiry, Salwan

“…A majority of recurrent pregnancy loss cases (RPL) remains unexplained. We hypothesized that complications in vascular and metabolic status may guide towards…”
Get full text

Reproductive Outcomes of Women with Turner Syndrome Undergoing Oocyte Vitrification: A Retrospective Multicenter Cohort Study by Nadesapillai, Sapthami, Mol, Femke, Broer, Simone L, Stevens Brentjens, Linda B. P. M, Verhoeven, Marieke O, Heida, Karst Y, Goddijn, Mariëtte, van Golde, Ron J. T, Bos, Annelies M. E, van der Coelen, Sanne, Peek, Ronald, Braat, Didi D. M, van der Velden, Janielle A. E. M, Fleischer, Kathrin

“…Background: Turner syndrome (TS) is accompanied with premature ovarian insufficiency. Oocyte vitrification is an established method to preserve fertility…”
Get full text

Clinical-grade whole genome sequencing-based haplarithmisis enables all forms of preimplantation genetic testing by Janssen, Anouk E. J., Koeck, Rebekka M., Essers, Rick, Cao, Ping, van Dijk, Wanwisa, Drüsedau, Marion, Meekels, Jeroen, Yaldiz, Burcu, van de Vorst, Maartje, de Koning, Bart, Hellebrekers, Debby M. E. I., Stevens, Servi J. C., Sun, Su Ming, Heijligers, Malou, de Munnik, Sonja A., van Uum, Chris M. J., Achten, Jelle, Hamers, Lars, Naghdi, Marjan, Vissers, Lisenka E. L. M., van Golde, Ron J. T., de Wert, Guido, Dreesen, Jos C. F. M., de Die-Smulders, Christine, Coonen, Edith, Brunner, Han G., van den Wijngaard, Arthur, Paulussen, Aimee D. C., Zamani Esteki, Masoud

“…High-throughput sequencing technologies have increasingly led to discovery of disease-causing genetic variants, primarily in postnatal multi-cell DNA samples…”
Get full text

Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology by Spaan, Mandy, van den Belt-Dusebout, Alexandra W, Lambalk, Cornelis B, van Boven, Hester H, Schats, Roel, Kortman, Marian, Broekmans, Frank J M, Laven, Joop S E, van Santbrink, Evert J P, Braat, Didi D M, van der Westerlaken, Lucette A J, Cohlen, Ben J, Cantineau, Astrid E P, Smeenk, Jesper M J, van Rumste, Minouche M, Goddijn, Mariëtte, van Golde, Ron J T, Meeuwissen, Paul A M, Hamilton, Carl J C M, Ouwens, Gabriële M, Gerritsma, Miranda A, Schaapveld, Michael, Burger, Curt W, van Leeuwen, Flora E

“…Abstract Background Long-term effects of assisted reproductive technology (ART) on ovarian tumor risk are unknown. Methods This nationwide cohort study…”
Get full text

Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer by van den Belt-Dusebout, Alexandra W, Spaan, Mandy, Lambalk, Cornelis B, Kortman, Marian, Laven, Joop S. E, van Santbrink, Evert J. P, van der Westerlaken, Lucette A. J, Cohlen, Ben J, Braat, Didi D. M, Smeenk, Jesper M. J, Land, Jolande A, Goddijn, Mariëtte, van Golde, Ron J. T, van Rumste, Minouche M, Schats, Roel, Józwiak, Katarzyna, Hauptmann, Michael, Rookus, Matti A, Burger, Curt W, van Leeuwen, Flora E

“…IMPORTANCE: Previous studies of breast cancer risk after in vitro fertilization (IVF) treatment were inconclusive due to limited follow-up. OBJECTIVE: To…”
Get full text

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers by Derks-Smeets, Inge A. P., Schrijver, Lieske H., de Die-Smulders, Christine E. M., Tjan-Heijnen, Vivianne C. G., van Golde, Ron J. T., Smits, Luc J., Caanen, Beppy, van Asperen, Christi J., Ausems, Margreet, Collée, Margriet, van Engelen, Klaartje, Kets, C. Marleen, van der Kolk, Lizet, Oosterwijk, Jan C., van Os, Theo A. M., Rookus, Matti A., van Leeuwen, Flora E., Gómez García, Encarna B.

“…Background The effect of in vitro fertilisation (IVF) on breast cancer risk for BRCA1/2 mutation carriers is rarely examined. As carriers may increasingly…”
Get full text

Counseling young women with early breast cancer on fertility preservation by ter Welle-Butalid, M. E. (Elena), Vriens, I. J. H. (Ingeborg), Derhaag, J. G. (Josien), Leter, E. M. (Edward), de Die-Smulders, C. E. (Christine), Smidt, M. (Marjolein), van Golde, R. J. T. (Ron), Tjan-Heijnen, V. C. G. (Vivianne)

“…Purpose Women with early-stage breast cancer may still have a future child wish, while chemotherapy may impair fertility. To pursue on fertility preservation…”
Get full text

Cumulative live birth rates in low-prognosis women by Leijdekkers, Jori A, Eijkemans, Marinus J C, van Tilborg, Theodora C, Oudshoorn, Simone C, van Golde, Ron J T, Hoek, Annemieke, Lambalk, Cornelis B, de Bruin, Jan Peter, Fleischer, Kathrin, Mochtar, Monique H, Kuchenbecker, Walter K H, Laven, Joop S E, Mol, Ben Willem J, Torrance, Helen L, Broekmans, Frank J M

“…Abstract STUDY QUESTION Do cumulative live birth rates (CLBRs) over multiple IVF/ICSI cycles confirm the low prognosis in women stratified according to the…”
Get full text

Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis by van Tilborg, Theodora C, Oudshoorn, Simone C, Eijkemans, Marinus J C, Mochtar, Monique H, van Golde, Ron J T, Hoek, Annemieke, Kuchenbecker, Walter K H, Fleischer, Kathrin, de Bruin, Jan Peter, Groen, Henk, van Wely, Madelon, Lambalk, Cornelis B, Laven, Joop S E, Mol, Ben Willem J, Broekmans, Frank J M, Torrance, Helen L

“…Is there a difference in live birth rate and/or cost-effectiveness between antral follicle count (AFC)-based individualized FSH dosing or standard FSH dosing…”
Get full text

A multicentre double-blinded randomized controlled trial on the efficacy of laser-assisted hatching in patients with repeated implantation failure undergoing IVF or ICSI by Curfs, Max H J M, Cohlen, Ben J, Slappendel, Els J, Schoot, Dick C, Derhaag, Josien G, van Golde, Ron J T, van der Heijden, Godfried W, Baart, Esther B, Smeenk, Jesper M J, Ritfeld, Victoria E E G, Brohet, Richard M, van Bavel, Casandra C A W

“…Abstract STUDY QUESTION Does assisted hatching increase the cumulative live birth rate in subfertile couples with repeated implantation failure? SUMMARY ANSWER…”
Get full text

Pregnancy rate and time to pregnancy after recurrent implantation failure (RIF)-a prospective cohort follow-up study by Stevens Brentjens, Linda B P M, Roumen, Relinde J E, Smits, Luc, Derhaag, Josien, Romano, Andrea, van Golde, Ron J T, den Hartog, Janneke E

“…The goal of this study was to determine ongoing pregnancy rate, time to pregnancy and embryo transfers to pregnancy within a cohort of patients with recurrent…”
Get full text

Outcomes of female fertility preservation with cryopreservation of oocytes or embryos in the Netherlands: a population-based study by Ter Welle-Butalid, M Elena, Derhaag, Josien G, van Bree, Bo E, Vriens, Ingeborg J H, Goddijn, Mariëtte, Balkenende, Eva M E, Beerendonk, Catharina C M, Bos, Anna M E, Homminga, Irene, Benneheij, Sofie H, van Os, H C, Smeenk, Jesper M J, Verhoeven, Marieke O, van Bavel, Casandra C A W, Tjan-Heijnen, Vivianne C G, van Golde, Ron J T

“…What are the reproductive outcomes of patients who cryopreserved oocytes or embryos in the context of fertility preservation in the Netherlands? This study…”
Get full text

Tubal flushing with oil-based or water-based contrast at hysterosalpingography for infertility: long-term reproductive outcomes of a randomized trial by van Rijswijk, Joukje, van Welie, Nienke, Dreyer, Kim, Pham, Clarabelle T., Verhoeve, Harold R., Hoek, Annemieke, de Bruin, Jan Peter, Nap, Annemiek W., van Hooff, Machiel H.A., Goddijn, Mariëtte, Hooker, Angelo B., Bourdrez, Petra, van Dongen, Angelique J.C.M., van Rooij, Ilse A.J., van Rijnsaardt-Lukassen, Henrike G.M., van Golde, Ron J.T., van Heteren, Cathelijne F., Pelinck, Marie J., Duijn, Annette E.J., Kaplan, Mesrure, Lambalk, Cornelis B., Mijatovic, Velja, Mol, Ben W.J.

“…To determine the impact of oil-based versus water-based contrast on pregnancy and live birth rates ≤5 years after hysterosalpingography (HSG) in infertile…”
Get full text

Considerations of breast cancer survivors to return for embryo transfer after fertility preservation: A qualitative study by ter Welle - Butalid, Maria Elena, van Osch, Liesbeth, van Bree, Bo E., Vriens, Ingeborg J.H., Derhaag, Josien G., de Die - Smulders, Christine E.M., Tjan - Heijnen, Vivianne C.G., van Golde, Ron J.T.

“…•First qualitative research of considerations of women after fertility preservation.•Women are strongly motivated to try natural conception after fertility…”
Get full text

The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status by C E, Drechsel Katja, C, van Tilborg Theodora, J C, Eijkemans Marinus, G W M, Lentjes Eef, Irene, Homminga, Mariette, Goddijn, J T, van Golde Ron, Willem, Verpoest, D, Lichtenbelt Klaske, J M, Broekmans Frank, M E, Bos Anna

“…This study aimed to investigate whether female BRCA1- and BRCA2 mutation carriers have a reduced ovarian reserve status, based on serum anti-Mullerian hormone…”
Get more information

The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial by Nahuis, Marleen J, Weiss, Nienke S, van der Veen, Fulco, Mol, Ben Willem J, Hompes, Peter G, Oosterhuis, Jur, Lambalk, Nils B, Smeenk, Jesper M J, Koks, Carolien A M, van Golde, Ron J T, Laven, Joop S E, Cohlen, Ben J, Fleischer, Kathrin, Goverde, Angelique J, Gerards, Marie H, Klijn, Nicole F, Nekrui, Lizka C M, van Rooij, Ilse A J, Hoozemans, Diederik A, van Wely, Madelon

“…Clomiphene citrate (CC) is first line treatment in women with World Health Organization (WHO) type II anovulation and polycystic ovary syndrome (PCOS). Whereas…”
Get full text

No evidence for a diminished ovarian reserve among patients with hypertensive disorders of pregnancy: a case control study by van Bree, Bo E, Jorissen, Laura M, Pattinaja, Désirée A P M, Bons, Judith A P, Spaanderman, Marc E A, Valkenburg, Olivier, van Golde, Ron J T

“…Existing evidence suggests a relation between cardiovascular dysfunction and diminished ovarian reserve. While it is known that pre-existent cardiovascular…”
Get full text

Improving patient-centredness in partnership with female patients: a cluster RCT in fertility care by Huppelschoten, Aleida G., Nelen, Willianne L.D.M., Westert, Gert P., van Golde, Ron J.T., Adang, Eddy M.M., Kremer, Jan A.M.

“…SUMMARY QUESTION What is the effect of a multifaceted intervention with participation of patients on improvement of patient-centredness in fertility care?…”
Get full text

The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients by Vriens, Ingeborg J H, De Bie, Ashley J R, Aarts, Maureen J B, de Boer, Maaike, van Hellemond, Irene E G, Roijen, Joyce H E, van Golde, Ron J T, Voogd, Adri C, Tjan-Heijnen, Vivianne C G

“…To assess the incidence of chemotherapy-induced ovarian function failure (COFF) based on estradiol and follicle stimulating hormone (FSH) monitoring in…”
Get full text